- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Ascendis Pharma
Market Cap: US$13.6b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$221.88
7D
-4.0%
1Y
32.1%
Madrigal Pharmaceuticals
Market Cap: US$10.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$447.72
7D
1.6%
1Y
29.2%
Insmed
Market Cap: US$29.3b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$143.98
7D
-0.4%
1Y
81.4%
Alnylam Pharmaceuticals
Market Cap: US$41.4b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$306.66
7D
-3.8%
1Y
5.5%
BridgeBio Pharma
Market Cap: US$13.3b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$69.60
7D
-2.0%
1Y
87.0%
BeOne Medicines
Market Cap: US$30.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$274.73
7D
-5.2%
1Y
8.5%
Ionis Pharmaceuticals
Market Cap: US$11.7b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$70.79
7D
-2.1%
1Y
111.6%
AbbVie
Market Cap: US$362.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$204.93
7D
-7.5%
1Y
-2.0%
Jazz Pharmaceuticals
Market Cap: US$11.1b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$182.32
7D
0.2%
1Y
28.4%
Eli Lilly
Market Cap: US$810.0b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$910.55
7D
-7.9%
1Y
5.3%
BioMarin Pharmaceutical
Market Cap: US$10.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.78
7D
-4.6%
1Y
-23.9%
Natera
Market Cap: US$27.7b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$200.09
7D
1.2%
1Y
30.1%
Royalty Pharma
Market Cap: US$26.2b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$45.61
7D
-1.1%
1Y
35.1%
Viatris
Market Cap: US$15.2b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.29
7D
-1.6%
1Y
42.9%
Exact Sciences
Market Cap: US$20.0b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$104.91
7D
1.0%
1Y
122.8%
Elanco Animal Health
Market Cap: US$11.9b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.98
7D
2.5%
1Y
124.3%
Waters
Market Cap: US$29.3b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$301.81
7D
4.1%
1Y
-19.2%